Montesinos, P., Burguera, A. D. L. F., Avila, S. G., Cluzeau, T., Garciaz, S., Madry, K., Prejzner, W., Mazan, M., Pakulska, U., Glowniak, U., Kulis, J., Coelho, D., Obacz, M., Sroka-Porada, A., Wilkinson, G., Windak, R., Dudziak, R., Saba, C., Rzymski, T., Nogai, H., Papayannidis, C., Marconi, G., Dybko, J., Burgues, J. M. B., Giannini, M. B., Audisio, E. (2025). Preliminary results from RIVER-81, a phase 2 study of romaciclib (RVU120) + venetoclax in patients with acute myeloid leukemia failing first-line venetoclax + hypomethylating agent (HMA). Blood. https://doi.org/10.1182/blood-2025-3424